Molnlycke Holding AB, founded in 1849 and headquartered in Gothenburg, Sweden, is a global leader in advanced wound care and surgical products. The company specializes in developing innovative medical solutions, including dressings, surgical drapes, and solutions that enhance patient care and improve clinical outcomes.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| MOLNLY 0.63% 2031-01-15 EURMolnlycke Holding AB | Sweden | 2031-01-15 | 0.625 | 3.18 |
| MOLNLY 0.88% 2029-09-05 EURMolnlycke Holding AB | Sweden | 2029-09-05 | 0.875 | 2.88 |
| MOLNLY 1.88% 2025-02-28 EURMolnlycke Holding AB | Sweden | 2025-02-28 | 1.875 | 0.00 |
| MOLNLY 4.25% 2028-09-08 EURMolnlycke Holding AB | Sweden | 2028-09-08 | 4.250 | 2.76 |
| MOLNLY 4.25% 2034-06-11 EURMolnlycke Holding AB | Sweden | 2034-06-11 | 4.250 | 3.73 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Molnlycke has a history of bond issuances, beginning in the early 2000s to support its expansion strategy. Significant issuances include a €300 million bond raised in 2017, which was used for acquisitions and enhancing its product portfolio. Current yields on Molnlycke's bonds are competitive within the healthcare sector, reflecting strong investor confidence and consistent financial performance. Additionally, the company offers bonds with attractive features such as callable options, enhancing their appeal in volatile markets.